Bleeding Disorders and Platelet Dysfunction

Understanding bleeding disorders rooted in platelet dysfunction is crucial for any aspiring clinician. These conditions frequently manifest not as deep tissue bleeds but as distinctive mucocutaneous bleeding—a pattern you must recognize to diagnose effectively and prevent life-threatening complications. On the MCAT and in medical school, you'll be tested on the precise pathophysiology that differentiates these disorders, from common inherited conditions to urgent hematologic emergencies.

Platelets and the Mucocutaneous Bleeding Pattern

Platelets are small, anucleate cell fragments crucial for primary hemostasis—the initial plug that stops bleeding at a vessel injury site. They adhere to exposed collagen, activate, aggregate, and provide a surface for coagulation factors. When platelets are deficient or dysfunctional, this primary plug fails to form properly. This failure leads to the classic mucocutaneous bleeding pattern: superficial bleeding from small vessels in the skin and mucous membranes. You will see this as petechiae (pinpoint red spots), purpura (larger bruised areas), epistaxis (nosebleeds), gingival bleeding, and menorrhagia. This contrasts with coagulation factor deficiencies (like hemophilia), which typically cause delayed deep tissue bleeding and hemarthroses (joint bleeds).

Thrombocytopenia: A Quantitative Platelet Defect

Thrombocytopenia is defined as a platelet count below 150,000 per microliter. Bleeding risk generally increases as the count falls, with spontaneous mucocutaneous bleeding often becoming apparent below 30,000/µL and a high risk of spontaneous internal hemorrhage below 10,000/µL. The mechanism is straightforward: there are simply not enough platelets to form an adequate hemostatic plug. Causes are broadly categorized into three processes: decreased production (e.g., bone marrow suppression), increased destruction (most common, often immune-mediated), and sequestration (e.g., in an enlarged spleen). Your diagnostic approach must differentiate between these pathways using history, physical exam, and lab work, starting with a complete blood count (CBC) and peripheral blood smear.

Immune Thrombocytopenic Purpura (ITP)

Immune thrombocytopenic purpura (ITP) is a classic example of increased platelet destruction. It is an autoimmune condition where the body produces anti-platelet antibodies, primarily IgG, that coat platelets. These antibody-coated platelets are then recognized and phagocytosed by macrophages in the spleen, drastically shortening their lifespan. ITP typically presents with isolated thrombocytopenia (low platelets only) on a CBC, with a normal white and red blood cell count. The peripheral smear shows large (young) platelets because the bone marrow compensates by increasing production. In children, ITP often follows a viral infection and is usually acute and self-limiting. In adults, it is more often chronic. First-line treatment is often corticosteroids to suppress the immune response, with IV immunoglobulin used in acute crises.

Thrombotic Thrombocytopenic Purpura (TTP): A Hematologic Emergency

While ITP involves simple destruction, thrombotic thrombocytopenic purpura (TTP) is a devastating thrombotic microangiopathy. The root cause is a severe deficiency (typically <10% of normal) of the enzyme ADAMTS13. This enzyme's job is to cleave large, sticky multimers of von Willebrand factor (vWF) that are released from endothelial cells. Without ADAMTS13, these ultra-large vWF multimers accumulate in the blood, causing spontaneous platelet adhesion and aggregation in small vessels throughout the body. This leads to the classic pentad of symptoms, which you should memorize for the MCAT:

1. Microangiopathic Hemolytic Anemia (MAHA): RBCs are physically sheared apart by fibrin strands in the microthrombi, seen on smear as schistocytes (fragmented RBCs).
2. Thrombocytopenia: Platelets are consumed in the widespread microthrombi.
3. Neurologic symptoms (confusion, headache, seizures).
4. Renal failure (due to thrombi in renal vasculature).
5. Fever.

In practice, not all five are required for diagnosis; the key triad is MAHA, thrombocytopenia, and a clinical story. TTP is a medical emergency treated with daily plasma exchange (to replace ADAMTS13 and remove antibodies) and immunosuppression.

Von Willebrand Disease: A Qualitative Adhesion Defect

Von Willebrand disease is the most common inherited bleeding disorder. It is caused by a quantitative or qualitative defect in von Willebrand factor (vWF), a large glycoprotein that performs two critical functions: it acts as the "glue" that allows platelets to adhere to exposed collagen at a site of injury, and it is the carrier protein that stabilizes factor VIII in circulation. Therefore, its deficiency leads to a dual defect in primary hemostasis (poor platelet adhesion) and a secondary, mild coagulation factor deficiency (low factor VIII). Patients present with a mucocutaneous bleeding pattern—easy bruising, menorrhagia, prolonged bleeding after dental work. Diagnosis involves tests like vWF antigen, vWF activity (ristocetin cofactor assay), and factor VIII level. Treatment often involves desmopressin (DDAVP), which releases vWF from endothelial stores, or vWF-containing factor concentrates.

Common Pitfalls

1. Confusing ITP and TTP on a Peripheral Smear: Both cause thrombocytopenia, but the smear tells the story. ITP shows large platelets only. TTP shows schistocytes (from MAHA) and possibly decreased platelets. Seeing schistocytes should immediately trigger concern for a microangiopathic process like TTP.
2. Misattributing the Bleeding Pattern: Assuming joint bleeds or deep hematomas are from platelet disorders is a classic error. Remember: platelet problems = superficial, mucosal, immediate bleeding. Coagulation factor problems = deep, delayed, joint/muscle bleeding. This distinction is high-yield for exams.
3. Overlooking the Role of vWF: Thinking of von Willebrand disease only as a "platelet adhesion disorder" overlooks its critical role in stabilizing factor VIII. This is why some patients with severe vWD may have a bleeding phenotype that partially mimics hemophilia.
4. Forgetting to Check Medication History: Many drugs can cause thrombocytopenia (e.g., heparin-induced thrombocytopenia) or platelet dysfunction (e.g., aspirin, NSAIDs). A thorough medication history is a vital first step in evaluating any new bleeding disorder.

Summary

• Platelet disorders (quantitative like low count or qualitative like faulty function) cause a distinct mucocutaneous bleeding pattern (petechiae, purpura, epistaxis), unlike the deep tissue bleeding of coagulation factor deficiencies.
• Immune thrombocytopenic purpura (ITP) is caused by anti-platelet antibodies leading to splenic platelet destruction, presenting with isolated thrombocytopenia and large platelets on smear.
• Thrombotic thrombocytopenic purpura (TTP) is a medical emergency due to ADAMTS13 deficiency, resulting in widespread microthrombi, consumptive thrombocytopenia, microangiopathic hemolytic anemia (schistocytes on smear), and potential renal/neurologic failure.
• Von Willebrand disease, the most common inherited bleeding disorder, involves defective von Willebrand factor, impairing platelet adhesion and Factor VIII stability, leading to mucocutaneous bleeding.